Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. March 15, 2018. Pamela Spence.

Executive Summary

Check out what Ernst & Young’s Pamela Spence had to say about the business threat to health-care firms from the tech world and how companies must respond.

"To seize the upside of disruption in this transformative age, life-sciences companies must look beyond novel drugs and devices, and invest, participate in or build platforms of care." –Pamela Spence, global life-sciences industry leader, Ernst & Young

Find out more: New Report Spotlights Intensifying Rivalry Between Tech And Health-Care Companies

Click here for a free trial of Medtech Insight

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT122329

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel